AMGN(AMGN)
AMGN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $37.77B | $38.75B | $39.73B | $41.07B | $42.64B |
| Low | $37.26B | $37.53B | $39.73B | $39.93B | $41.45B |
| High | $38.29B | $39.88B | $39.74B | $42.60B | $44.22B |
| EBITDA Avg | $17.24B | $17.68B | $18.13B | $18.74B | $19.46B |
| Low | $17.00B | $17.13B | $18.13B | $18.22B | $18.92B |
| High | $17.47B | $18.20B | $18.13B | $19.44B | $20.18B |
| EBIT Avg | $11.85B | $12.16B | $12.47B | $12.89B | $13.38B |
| Low | $11.69B | $11.78B | $12.46B | $12.53B | $13.01B |
| High | $12.01B | $12.51B | $12.47B | $13.37B | $13.87B |
| Net Income Avg | $11.86B | $12.37B | $13.52B | $13.99B | $14.87B |
| Low | $11.19B | $11.43B | $10.40B | $13.48B | $14.34B |
| High | $12.54B | $13.30B | $16.64B | $14.66B | $15.59B |
| EPS Avg | $22.38 | $23.41 | $24.34 | $25.81 | $27.44 |
| Low | $20.64 | $21.09 | $19.19 | $24.88 | $26.45 |
| High | $23.14 | $24.54 | $30.70 | $27.06 | $28.77 |
| Analysts (Rev / EPS) | 25 / 21 | 25 / 20 | 27 / 12 | 13 / 10 | 13 / 5 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $9.42B | $9.68B | $9.99B | $8.96B | $9.54B | $9.71B | $10.20B | $9.50B |
| Low | $9.33B | $9.48B | $9.72B | $8.72B | $9.29B | $9.45B | $9.93B | $9.24B |
| High | $9.51B | $9.80B | $10.23B | $9.17B | $9.77B | $9.94B | $10.44B | $9.72B |
| EBITDA Avg | $4.30B | $4.42B | $4.56B | $4.09B | $4.35B | $4.43B | $4.66B | $4.33B |
| Low | $4.26B | $4.33B | $4.44B | $3.98B | $4.24B | $4.31B | $4.53B | $4.22B |
| High | $4.34B | $4.47B | $4.67B | $4.19B | $4.46B | $4.54B | $4.77B | $4.44B |
| EBIT Avg | $2.96B | $3.04B | $3.13B | $2.81B | $2.99B | $3.05B | $3.20B | $2.98B |
| Low | $2.93B | $2.98B | $3.05B | $2.74B | $2.91B | $2.97B | $3.12B | $2.90B |
| High | $2.98B | $3.08B | $3.21B | $2.88B | $3.06B | $3.12B | $3.28B | $3.05B |
| Net Income Avg | $3.05B | $3.13B | $3.18B | $2.95B | $3.26B | $3.25B | $3.37B | $3.21B |
| Low | $2.91B | $2.93B | $3.07B | $2.84B | $3.15B | $3.13B | $3.26B | $3.10B |
| High | $3.17B | $3.24B | $3.28B | $3.04B | $3.36B | $3.35B | $3.48B | $3.31B |
| EPS Avg | $5.60 | $5.76 | $5.85 | $5.42 | $6.00 | $5.97 | $6.20 | $5.90 |
| Low | $5.35 | $5.39 | $5.64 | $5.23 | $5.79 | $5.76 | $5.99 | $5.70 |
| High | $5.83 | $5.96 | $6.03 | $5.59 | $6.18 | $6.15 | $6.40 | $6.09 |
| Analysts (Rev / EPS) | 15 / 19 | 15 / 18 | 11 / 16 | 7 / 8 | 7 / 8 | 7 / 13 | 7 / 8 | 6 / 9 |